Former Founder and CEO (company closed)
at ImVitro
Alexandra Boussommier-Calleja is an entrepreneur trained in biomedical engineering with extensive experience in biomechanical research and skilled in 2D and 3D cell culture, microfluidic models, in vitro and in vivo assay development.
After spending years learning to manipulate tissues and cells to mimic life in the lab, she became fascinated with the ability to manipulate cells to make life happen directly in the lab with in vitro fertilization (IVF).
She wanted to help the numerous people suffering from infertility worldwide, and founded ImVitro, a VC-backed deeptech digital health company that uses AI to tackle infertility and increase the number of successful IVF-assisted pregnancies for millions of would-be parents across the world. After more than five years leading an 18-person interdisciplinary team, raising over $4M from European and international investors, publishing five top-tier embryology papers, and deploying their software in 20 labs worldwide, the company closed in 2025.
Education
Swiss Federal Institute of Technology Lausanne (EPFL)
Awards & Certifications
Marie Curie Individual Fellowship S&E
Irvington Postdoctoral Fellowship
Santander Mobility Award
Euro-Bioimaging Proof-of-Concept Award
Entente Cordiale Postgraduate Scholarship
Accreditations
Doctor of Philosophy recognised by Imperial College London
Master of Science (MSc), Biomedical Engineering recognised by Imperial College London
Bachelor of Science (BSc), Life Science and Technology (Bioengineering) recognised by Swiss Federal Institute of Technology (EPFL)
Diploma recognised by Sorbonne University
Areas of Expertise
Got a Question for Alexandra Boussommier-Calleja, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
